ICI discovered tamoxifen before AstraZeneca bought them. They're British. Femara (letrozole) and Afinitor (everolimus) are Novartis (Switzerland). Campostar was discovered by Pharmacia, a Swedish company that's now part of Pfizer.
The U.S. by no means has a monopoly on "cancer drugs".
It would be interesting to see where the labs for those companies are, and what's their primary market.
But thanks, i didn't know that. Maybe the british and swiss R&D isn't in such a bad state as France.
But i just wanted to provide some perspective to that generaly over optimistic OP post. The fact that cancer drugs are created in the US is not a coincidence. It's an ecosystem where there is a lot of money to be made, and as we know it in IT, money drives innovation.